USA Autologous Matrix-Induced Chondrogenesis (AMIC) Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the USA Autologous Matrix-Induced Chondrogenesis (AMIC) market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Autologous Matrix-Induced Chondrogenesis (AMIC) market. Detailed analysis of key players, along with key growth strategies adopted by Autologous Matrix-Induced Chondrogenesis (AMIC) industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • CartiHeal

    • Arthro-Kinetics

    • Anika Therapeutics, Inc

    • BioTissue AG

    • Zimmer Biomet Holdings

    • Smith and Nephew plc

    • B Braun Melsungen AG

    • Geistlich Pharma AG

    • JRI Orthopaedics Ltd

    • Matricel GmbH

    By Type:

    • Hyaluronic Acid

    • Collagen

    • Polyethylene glycol (PEG)

    • polylactic-co-glycolic acid (PGLA)

    • Others

    By End-User:

    • Knee Cartilage Repair

    • Hip Cartilage Repair

    • Elbow Cartilage Repair

    • Others

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Autologous Matrix-Induced Chondrogenesis (AMIC) Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size and Growth Rate of Hyaluronic Acid from 2016 to 2027

      • 1.3.2 USA Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size and Growth Rate of Collagen from 2016 to 2027

      • 1.3.3 USA Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size and Growth Rate of Polyethylene glycol (PEG) from 2016 to 2027

      • 1.3.4 USA Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size and Growth Rate of polylactic-co-glycolic acid (PGLA) from 2016 to 2027

      • 1.3.5 USA Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size and Growth Rate of Others from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size and Growth Rate of Knee Cartilage Repair from 2016 to 2027

      • 1.4.2 USA Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size and Growth Rate of Hip Cartilage Repair from 2016 to 2027

      • 1.4.3 USA Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size and Growth Rate of Elbow Cartilage Repair from 2016 to 2027

      • 1.4.4 USA Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size and Growth Rate of Others from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Autologous Matrix-Induced Chondrogenesis (AMIC) Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Autologous Matrix-Induced Chondrogenesis (AMIC) by Major Types

      • 3.4.1 Market Size and Growth Rate of Hyaluronic Acid

      • 3.4.2 Market Size and Growth Rate of Collagen

      • 3.4.3 Market Size and Growth Rate of Polyethylene glycol (PEG)

      • 3.4.4 Market Size and Growth Rate of polylactic-co-glycolic acid (PGLA)

      • 3.4.5 Market Size and Growth Rate of Others

    4 Segmentation of Autologous Matrix-Induced Chondrogenesis (AMIC) Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Autologous Matrix-Induced Chondrogenesis (AMIC) by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Autologous Matrix-Induced Chondrogenesis (AMIC) in Knee Cartilage Repair

      • 4.4.2 Market Size and Growth Rate of Autologous Matrix-Induced Chondrogenesis (AMIC) in Hip Cartilage Repair

      • 4.4.3 Market Size and Growth Rate of Autologous Matrix-Induced Chondrogenesis (AMIC) in Elbow Cartilage Repair

      • 4.4.4 Market Size and Growth Rate of Autologous Matrix-Induced Chondrogenesis (AMIC) in Others

    5 Market Analysis by Regions

    • 5.1 USA Autologous Matrix-Induced Chondrogenesis (AMIC) Production Analysis by Regions

    • 5.2 USA Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Autologous Matrix-Induced Chondrogenesis (AMIC) Landscape Analysis

    • 6.1 West USA Autologous Matrix-Induced Chondrogenesis (AMIC) Landscape Analysis by Major Types

    • 6.2 West USA Autologous Matrix-Induced Chondrogenesis (AMIC) Landscape Analysis by Major End-Users

    7 South USA Autologous Matrix-Induced Chondrogenesis (AMIC) Landscape Analysis

    • 7.1 South USA Autologous Matrix-Induced Chondrogenesis (AMIC) Landscape Analysis by Major Types

    • 7.2 South USA Autologous Matrix-Induced Chondrogenesis (AMIC) Landscape Analysis by Major End-Users

    8 Middle West USA Autologous Matrix-Induced Chondrogenesis (AMIC) Landscape Analysis

    • 8.1 Middle West USA Autologous Matrix-Induced Chondrogenesis (AMIC) Landscape Analysis by Major Types

    • 8.2 Middle West USA Autologous Matrix-Induced Chondrogenesis (AMIC) Landscape Analysis by Major End-Users

    9 Northeast USA Autologous Matrix-Induced Chondrogenesis (AMIC) Landscape Analysis

    • 9.1 Northeast USA Autologous Matrix-Induced Chondrogenesis (AMIC) Landscape Analysis by Major Types

    • 9.2 Northeast USA Autologous Matrix-Induced Chondrogenesis (AMIC) Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 CartiHeal

        • 10.1.1 CartiHeal Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Arthro-Kinetics

        • 10.2.1 Arthro-Kinetics Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Anika Therapeutics, Inc

        • 10.3.1 Anika Therapeutics, Inc Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 BioTissue AG

        • 10.4.1 BioTissue AG Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Zimmer Biomet Holdings

        • 10.5.1 Zimmer Biomet Holdings Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Smith and Nephew plc

        • 10.6.1 Smith and Nephew plc Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 B Braun Melsungen AG

        • 10.7.1 B Braun Melsungen AG Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Geistlich Pharma AG

        • 10.8.1 Geistlich Pharma AG Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 JRI Orthopaedics Ltd

        • 10.9.1 JRI Orthopaedics Ltd Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 Matricel GmbH

        • 10.10.1 Matricel GmbH Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size and Growth Rate of Hyaluronic Acid from 2016 to 2027

    • Figure USA Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size and Growth Rate of Collagen from 2016 to 2027

    • Figure USA Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size and Growth Rate of Polyethylene glycol (PEG) from 2016 to 2027

    • Figure USA Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size and Growth Rate of polylactic-co-glycolic acid (PGLA) from 2016 to 2027

    • Figure USA Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size and Growth Rate of Knee Cartilage Repair from 2016 to 2027

    • Figure USA Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size and Growth Rate of Hip Cartilage Repair from 2016 to 2027

    • Figure USA Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size and Growth Rate of Elbow Cartilage Repair from 2016 to 2027

    • Figure USA Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Autologous Matrix-Induced Chondrogenesis (AMIC) Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Autologous Matrix-Induced Chondrogenesis (AMIC)

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Autologous Matrix-Induced Chondrogenesis (AMIC) by Different Types from 2016 to 2027

    • Table Consumption Share of Autologous Matrix-Induced Chondrogenesis (AMIC) by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Hyaluronic Acid

    • Figure Market Size and Growth Rate of Collagen

    • Figure Market Size and Growth Rate of Polyethylene glycol (PEG)

    • Figure Market Size and Growth Rate of polylactic-co-glycolic acid (PGLA)

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Autologous Matrix-Induced Chondrogenesis (AMIC) by Different End-Users from 2016 to 2027

    • Table Consumption Share of Autologous Matrix-Induced Chondrogenesis (AMIC) by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Knee Cartilage Repair

    • Figure Market Size and Growth Rate of Hip Cartilage Repair

    • Figure Market Size and Growth Rate of Elbow Cartilage Repair

    • Figure Market Size and Growth Rate of Others

    • Table USA Autologous Matrix-Induced Chondrogenesis (AMIC) Production by Regions

    • Table USA Autologous Matrix-Induced Chondrogenesis (AMIC) Production Share by Regions

    • Figure USA Autologous Matrix-Induced Chondrogenesis (AMIC) Production Share by Regions in 2016

    • Figure USA Autologous Matrix-Induced Chondrogenesis (AMIC) Production Share by Regions in 2021

    • Figure USA Autologous Matrix-Induced Chondrogenesis (AMIC) Production Share by Regions in 2027

    • Table USA Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption by Regions

    • Table USA Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by Regions

    • Figure USA Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by Regions in 2016

    • Figure USA Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by Regions in 2021

    • Figure USA Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by Regions in 2027

    • Table West USA Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption by Types from 2016 to 2027

    • Table West USA Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by Types from 2016 to 2027

    • Figure West USA Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by Types in 2016

    • Figure West USA Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by Types in 2021

    • Figure West USA Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by Types in 2027

    • Table West USA Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption by End-Users from 2016 to 2027

    • Table West USA Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by End-Users in 2016

    • Figure West USA Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by End-Users in 2021

    • Figure West USA Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by End-Users in 2027

    • Table South USA Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption by Types from 2016 to 2027

    • Table South USA Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by Types from 2016 to 2027

    • Figure South USA Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by Types in 2016

    • Figure South USA Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by Types in 2021

    • Figure South USA Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by Types in 2027

    • Table South USA Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption by End-Users from 2016 to 2027

    • Table South USA Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by End-Users in 2016

    • Figure South USA Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by End-Users in 2021

    • Figure South USA Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by End-Users in 2027

    • Table Middle West USA Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption by Types from 2016 to 2027

    • Table Middle West USA Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by Types in 2016

    • Figure Middle West USA Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by Types in 2021

    • Figure Middle West USA Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by Types in 2027

    • Table Middle West USA Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by End-Users in 2016

    • Figure Middle West USA Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by End-Users in 2021

    • Figure Middle West USA Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by End-Users in 2027

    • Table Northeast USA Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption by Types from 2016 to 2027

    • Table Northeast USA Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by Types in 2016

    • Figure Northeast USA Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by Types in 2021

    • Figure Northeast USA Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by Types in 2027

    • Table Northeast USA Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by End-Users in 2016

    • Figure Northeast USA Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by End-Users in 2021

    • Figure Northeast USA Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of CartiHeal

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CartiHeal

    • Figure Sales and Growth Rate Analysis of CartiHeal

    • Figure Revenue and Market Share Analysis of CartiHeal

    • Table Product and Service Introduction of CartiHeal

    • Table Company Profile and Development Status of Arthro-Kinetics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Arthro-Kinetics

    • Figure Sales and Growth Rate Analysis of Arthro-Kinetics

    • Figure Revenue and Market Share Analysis of Arthro-Kinetics

    • Table Product and Service Introduction of Arthro-Kinetics

    • Table Company Profile and Development Status of Anika Therapeutics, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Anika Therapeutics, Inc

    • Figure Sales and Growth Rate Analysis of Anika Therapeutics, Inc

    • Figure Revenue and Market Share Analysis of Anika Therapeutics, Inc

    • Table Product and Service Introduction of Anika Therapeutics, Inc

    • Table Company Profile and Development Status of BioTissue AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioTissue AG

    • Figure Sales and Growth Rate Analysis of BioTissue AG

    • Figure Revenue and Market Share Analysis of BioTissue AG

    • Table Product and Service Introduction of BioTissue AG

    • Table Company Profile and Development Status of Zimmer Biomet Holdings

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Zimmer Biomet Holdings

    • Figure Sales and Growth Rate Analysis of Zimmer Biomet Holdings

    • Figure Revenue and Market Share Analysis of Zimmer Biomet Holdings

    • Table Product and Service Introduction of Zimmer Biomet Holdings

    • Table Company Profile and Development Status of Smith and Nephew plc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Smith and Nephew plc

    • Figure Sales and Growth Rate Analysis of Smith and Nephew plc

    • Figure Revenue and Market Share Analysis of Smith and Nephew plc

    • Table Product and Service Introduction of Smith and Nephew plc

    • Table Company Profile and Development Status of B Braun Melsungen AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of B Braun Melsungen AG

    • Figure Sales and Growth Rate Analysis of B Braun Melsungen AG

    • Figure Revenue and Market Share Analysis of B Braun Melsungen AG

    • Table Product and Service Introduction of B Braun Melsungen AG

    • Table Company Profile and Development Status of Geistlich Pharma AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Geistlich Pharma AG

    • Figure Sales and Growth Rate Analysis of Geistlich Pharma AG

    • Figure Revenue and Market Share Analysis of Geistlich Pharma AG

    • Table Product and Service Introduction of Geistlich Pharma AG

    • Table Company Profile and Development Status of JRI Orthopaedics Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of JRI Orthopaedics Ltd

    • Figure Sales and Growth Rate Analysis of JRI Orthopaedics Ltd

    • Figure Revenue and Market Share Analysis of JRI Orthopaedics Ltd

    • Table Product and Service Introduction of JRI Orthopaedics Ltd

    • Table Company Profile and Development Status of Matricel GmbH

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Matricel GmbH

    • Figure Sales and Growth Rate Analysis of Matricel GmbH

    • Figure Revenue and Market Share Analysis of Matricel GmbH

    • Table Product and Service Introduction of Matricel GmbH


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.